
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Parexel has announced it has completed the acquisition of Model Answers. As part of the acquisition, the Model Answers’ staff have joined Parexel’s growing Clinical Pharmacology, Modeling and Simulation team.
For further details on this acquisition, click






